The giant retailer is a bellwether for the economy and the health of the consumer.
Walmart raised FY guidance to 4-5% on 5.9% Q revenue ($187.9B), ecommerce-driven; Medicare drug-price declines offset gains. Retail edge hinges on online logistics and dynamic pricing; regulatory margin pressure accelerates automation stack investment.
Add Axios as your preferred source to
see more of our stories on Google.
Illustration: Sarah Grillo/Axios
Walmart raised its sales and earnings forecast Thursday, powered by a strong performance in the company's online business, although declines in drug prices hurt sales.
Why it matters: As the world's largest retailer, Walmart is a bellwether for the economy and the health of the consumer.
Walmart’s Slowdown Spotlights Amazon’s Strength
Walmart warns US shoppers feel squeeze as sales growth slows
Walmart Reports Slowest U.S. Sales Growth Since Pandemic
Walmart strong again in second quarter, but its outlook is reserved
Walmart Reports Slowest Sales Growth In 6 Years, Shares Tumble
Walmart stock falls over 8% after rare quarterly sales miss
Dow Jones Top Company Headlines at 5 PM ET: Walmart Shares Slump on Weakest Sales Growth in Over Six Years | Ross ...
Consumer Cos Down as Walmart Plunges on Earnings - Consumer Roundup
Dow Jones Top Company Headlines at 7 PM ET: Walmart Shares Slump on Weakest Sales Growth in Over Six Years | Ross ...
Walmart cautious with expectations after slowest sales growth in six years
